Development and preliminary validation of a pain measure specific to neuropathic pain

Article abstract-Neuropathic pain syndromes are commonly seen in clinical practice and are frequently used as pain models in testing new therapies. However, no pain scale exists with the primary purpose to measure pain in neuropathic syndromes. This paper describes the development and preliminary validation of the Neuropathic Pain Scale (NPS), which is designed to assess distinct pain qualities associated with neuropathic pain. Results support the discriminant and predictive validity of the NPS items. Moreover, the NPS items appear to be sensitive to treatments known to impact neuropathic pain. These findings provide support for the further development of the NPS. NEUROLOGY 1997;48: 332-338

[1]  R. Penn,et al.  Neurosurgical horizons in Parkinson's disease , 1993, Neurology.

[2]  K. Anand,et al.  Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery. , 1992, The New England journal of medicine.

[3]  J. Kurtzke,et al.  On the production of neurologists in the United States , 1991, Neurology.

[4]  M. Rowbotham,et al.  Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury , 1993, Neurology.

[5]  R. Gracely.  Evaluation of multi-dimensional pain scales , 1992, Pain.

[6]  J. Ochoa,et al.  Phentolamine sympathetic block in painful polyneuropathies , 1994, Neurology.

[7]  Ronald Dubner,et al.  Ratio scales of sensory and affective verbal pain descriptors , 1978, Pain.

[8]  K. Davis,et al.  Systemic alpha-adrenergic blockade with phentolamine: a diagnostic test for sympathetically maintained pain. , 1991, Anesthesiology.

[9]  D. Kooy,et al.  Post-herpetic neuralgia: Further post-mortem studies of cases with and without pain , 1991, Pain.

[10]  López Piñero Jm,et al.  New material and information about the History of the plants of New Spain by Francisco Hernandez , 1994 .

[11]  V. Chadda,et al.  Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy. , 1978, The Journal of the Association of Physicians of India.

[12]  M. Ellenberg.  Treatment of diabetic neuropathy with diphenylhydantoin. , 1968, New York state journal of medicine.

[13]  R Dubner,et al.  Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. , 1992, The New England journal of medicine.

[14]  R. Melzack.  The McGill Pain Questionnaire: Major properties and scoring methods , 1975, PAIN.

[15]  S. Samantaray,et al.  Diabetic peripheral neuropathy: nerve conduction studies before, during and after carbamazepine therapy. , 1976, Australian and New Zealand journal of medicine.

[16]  M. Rowbotham,et al.  Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia , 1991, Neurology.

[17]  R. Meyer,et al.  Is Nociceptor Activation by Alpha-1 Adrenoreceptors the Culprit in Sympathetically Maintained Pain? , 1992 .

[18]  J. Kastrup,et al.  Intravenous lidocaine infusion — a new treatment of chronic painful diabetic neuropathy? , 1987, Pain.

[19]  Paul Karoly,et al.  Self-report scales and procedures for assessing pain in adults , 1992 .